PegBio Co., Ltd. (HKG:2565)
Hong Kong · Delayed Price · Currency is HKD 8.52
-0.30 (-3.40%)
Last updated: May 28, 2026, 11:59 AM HKT
PegBio Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
58
Market Cap
3.45B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | 242.40K | 133.56K | 122.72% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Qyuns Therapeutics | 897.99M |
| Shandong Boan Biotechnology | 873.36M |
| BioDlink International Company | 831.99M |
| Medtide | 634.40M |
| Mirxes Holding Company | 166.32M |
| Antengene Corporation | 117.22M |
| Jacobio Pharmaceuticals Group | 59.56M |
| Jiangsu Recbio Technology | 14.16M |